Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis.

Permpalung, Nitipong; Maertens, Johan; Marr, Kieren A

Permpalung, Nitipong; Maertens, Johan; Marr, Kieren A.

Permpalung N; Departments of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Electronic address: npermpa1@jhmi.edu.
Maertens J; Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Marr KA; Departments of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Lancet Infect Dis ; 21(6): 766-767, 2021 06.

Article in English | MEDLINE | ID: covidwho-1246251

Subject(s)

COVID-19; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Consensus; Humans; Invasive Pulmonary Aspergillosis/diagnosis; Invasive Pulmonary Aspergillosis/drug therapy; Pulmonary Aspergillosis/diagnosis; Pulmonary Aspergillosis/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Aspergillosis / Invasive Pulmonary Aspergillosis / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google